MSB 2.70% 95.0¢ mesoblast limited

I have been really disappointed by the tardiness of the NIH in...

  1. 7,573 Posts.
    lightbulb Created with Sketch. 6840
    I have been really disappointed by the tardiness of the NIH in this trial. You had a treatment that showed amazing results in patients on deaths door and six months after the first dosing we are not complete on a 300 patient trial.

    This was very formally and professionally done by MSB in the CSTN (trial network) with no involvement their end. Meanwhile every other company is out announcing premature and often subsequently failed results (Remdesivir etc). MSB are almost hamstrung by their professional approach, but in the long run results will be unequivocal.

    MSB always aimed to be part of a three pronged approach to COViD-19, with vaccines and anti-virals. The tortoise will ultimately end up beating the hares in that race, that we must hope all end up winners in with 1,500+ dying a day in the US alone.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.